Julie B. Feder
Overview
Julie B. Feder received an average of $1M in total compensation, including $352K in salary, at Aura Biosciences between 2020 and 2021. Julie Feder also received $1M at Verastem in 2017.
Source: SEC filings on April 28, 2022 and April 10, 2018.
Related executives
We found 12 more executives who work or worked at Aura Biosciences and Verastem.
Daniel Paterson
Verastem
Chief Executive Officer
Brian Stuglik
Verastem
Chief Executive Officer
Daniel Calkins
Verastem
Chief Financial Officer
Robert Gagnon
Verastem
Former Chief Business and Financial Officer
Elisabet Pinos
Aura Biosciences
Chief Executive Officer
Cadmus Rich
Aura Biosciences
Chief Medical Officer
Robert Forrester
Verastem
Chief Executive Officer
Joseph Lobacki
Verastem